ASN
HRMY icon

Advisory Services Network’s Harmony Biosciences HRMY Stock Holding History

Advisory Services Network’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-700
Closed -$19.6K – 3290
2026
Q1 		$19.6K Buy
+700
New +$23K ﹤0.01% 3215
2025
Q4 		– Sell
-700
Closed -$19.3K – 2915
2025
Q3 		$19.3K Buy
+700
New +$24.1K ﹤0.01% 2967
2024
Q1 		– Sell
-63
Closed -$2.04K – 2430
2023
Q4 		$2.04K Buy
+63
New +$1.76K ﹤0.01% 3396
2023
Q2 		– Sell
-126
Closed -$4.11K – 2417
2023
Q1 		$4.11K Sell
126
-10
-7% -$455 ﹤0.01% 3212
2022
Q4 		$7.49K Buy
+136
New +$7.48K ﹤0.01% 2962

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisory Services Network's HRMY Position: Q2 2026 in Review

Advisory Services Network sold out of Harmony Biosciences (HRMY) in Q2 2026, closing a stake of 700 shares — an estimated $19.6K sold.

Advisory Services Network first reported a position in HRMY in Q4 2022 and held it in 5 quarters. The position peaked at $19.6K in Q1 2026. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Advisory Services Network reported no remaining Harmony Biosciences position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 700 Harmony Biosciences shares in Q2 2026, an estimated $19.6K.
  • Advisory Services Network first reported a position in Harmony Biosciences in Q4 2022 and held it in 5 quarters.
  • Advisory Services Network's Harmony Biosciences position peaked at $19.6K in Q1 2026.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.